Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ADC doses first patient in phase I trial of ADCT-601 in advanced solid tumors
Image: ADC Therapeutics announces first patient dosed in Phase I clinical trial of ADCT-601 in advanced solid tumors. Photo: courtesy of ponsulak/Freedigitalphotos.net.
Image: ADC Therapeutics announces first patient dosed in Phase I clinical trial of ADCT-601 in advanced solid tumors. Photo: courtesy of ponsulak/Freedigitalphotos.net.